(Total Views: 315)
Posted On: 08/27/2018 5:52:17 PM
Post# of 72445
Re: scottyincuffs #48079
First thing to note is Galera has not even completed its Phase 2 OM (GC4419) drug, but yet they have already gotten their Breakthrough Therapy Designation (BTD).
https://clinicaltrials.gov/ct2/show/NCT02508389?term=GC4419
Whereas, for IPIX, they have completed B-OM Phase 2 trial but with no BTD in sight as of now . What gives? And will questioning this is considered bashing as well?
https://clinicaltrials.gov/ct2/show/NCT02324335
You can do a search here to see if IPIX has gotten any BTD for B-OM.
https://www.focr.org/breakthrough-therapies
https://clinicaltrials.gov/ct2/show/NCT02508389?term=GC4419
Whereas, for IPIX, they have completed B-OM Phase 2 trial but with no BTD in sight as of now . What gives? And will questioning this is considered bashing as well?
https://clinicaltrials.gov/ct2/show/NCT02324335
You can do a search here to see if IPIX has gotten any BTD for B-OM.
https://www.focr.org/breakthrough-therapies
(0)
(1)
